Intuitive Surgical (ISRG) Nears Third Quarter Earnings, Is It Still Above Fair Value?

Intuitive Surgical (ISRG) heads into its 20 October third quarter earnings report with investor attention fixed on procedure trends, system demand, recurring revenue resilience, pricing pressure, and fresh competition from Johnson & Johnson's FDA cleared OTTAVA robotic platform.

Recent trading in Intuitive Surgical reflects that tension between near term uncertainty and longer term conviction. The share price is up 8.5% over the past month and 20.8% over 90 days, yet remains down 24.1% year to date, while the 3 year total shareholder return of 59.9% points to momentum that has built over a longer horizon.

Spot opportunities across surgical robotics and automation by scanning a curated list of 91 robotics and automation stocks alongside Intuitive Surgical ahead of this earnings test.

Bulls see Intuitive Surgical’s pullback as a reset after years of strong adoption. Bears see a premium price colliding with new rivals. The recent rebound prompts a closer look at what the current valuation really assumes.

Most Popular Narrative: 30% Overvalued

At a last close of $426.70, Intuitive Surgical is trading well above the most followed narrative fair value of about $342, which frames expectations heading into earnings and shapes how much good news is already priced in.

The model assumes future revenue growth of 14.7% annually, a long-term net profit margin of 25% compared with the current 28.45%, and a 35x exit P/E compared with the current 46.76x. These assumptions produce a five-year fair-value estimate of USD 342.74. This fair value is an estimate based on the stated assumptions, not a buy or sell recommendation.

See why 2 investors see Intuitive Surgical as 30% overvalued.

Result: Fair Value of $342.74 (OVERVALUED)

Still, that story can break if hospital capital budgets tighten further, or if new entrants such as Johnson & Johnson’s OTTAVA erode Intuitive Surgical’s procedure share faster than expected.

Find out about the key risks to this Intuitive Surgical narrative.

Next Steps

Opinions on Intuitive Surgical’s current price are split, and that is exactly why the data matters most. To act quickly and evaluate the bullish side of the story, review the 2 key rewards

Looking for more investment ideas beyond Intuitive Surgical?

If Intuitive Surgical has sharpened your focus, do not stop at a single ticker. Broader research can reveal opportunities you might otherwise miss.

• Target resilient balance sheets by scanning companies with strong cash positions and low leverage through this list of solid balance sheet and fundamentals (25 results).
• Hunt for quality at a discount by reviewing a curated pool of 33 high quality undervalued stocks that pair fundamentals with potential upside.
• Spot potential future winners early by filtering for 20 high quality undiscovered gems that have solid financials but limited mainstream attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com